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  INTRODUCTION 
  Patients with cirrhosis are admitted to intensive care units 
(ICUs) for complications of portal hypertension such as variceal 
bleeding or hepatic encephalopathy, or for sepsis resulting 
from spontaneous bacterial peritonitis, chest or urinary tract 
infections, culminating in multiple-organ failure in a large 
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    OBJECTIVES:       Prognosis for patients with cirrhosis admitted to intensive care unit (ICU) is poor. ICU prognostic 
models are more accurate than liver-speciﬁ  c models. We identiﬁ  ed predictors of mortality, developed 
a novel prognostic score (Royal Free Hospital (RFH) score), and tested it against established 
prognostic models and the yet unvalidated Chronic Liver Failure-Sequential Organ Failure Assessment 
(CLIF-SOFA) model. 
    METHODS:       Predictors of mortality were deﬁ  ned by logistic regression in a cohort of 635 consecutive patients 
with cirrhosis admitted to ICU (1989  –  2012). The RFH score was derived using a 75  %   training and 
25  %   validation set. Predictive accuracy and calibration were evaluated using area under the receiver 
operating characteristic (AUROC) and goodness-of-ﬁ  t     χ      2   for the RFH score, as well as for SOFA, 
Model for End-Stage Liver Disease (MELD), Acute Physiology and Chronic Health Evaluation 
(APACHE II), and Child-Pugh. CLIF-SOFA was applied to a recent subset (2005  –  2012) of patients. 
    RESULTS:       In-hospital mortality was 52.3  %  . Mortality improved over time but with a corresponding reduc-
tion in acuity of illness on admission. Predictors of mortality in training set, which constituted the 
RFH score, were the following: bilirubin, international normalized ratio, lactate, alveolar arterial 
partial pressure oxygen gradient, urea, while variceal bleeding as indication for admission conferred 
lesser risk. Classiﬁ  cation accuracy was 73.4  %   in training and 76.7  %   in validation sample and did 
not change signiﬁ  cantly across different eras of admission. The AUROC for the derived model was 
0.83 and the goodness-of-ﬁ  t     χ      2   was 3.74 (  P        =      0.88). AUROC for SOFA was 0.81, MELD was 0.79, 
APACHE II was 0.78, and Child-Pugh was 0.67. In 2005  –  2012 cohort, AUROC was: SOFA: 0.74, 
CLIF-SOFA: 0.75, and RFH: 0.78. Goodness-of-ﬁ  t     χ      2   was: SOFA: 6.21 (  P        =      0.63), CLIF-SOFA: 9.18 
(  P        =      0.33), and RFH: 2.91 (  P        =      0.94). 
    CONCLUSIONS:       RFH score demonstrated good discriminative ability and calibration. Internal validation supports its 
generalizability. CLIF-SOFA did not perform better than RFH and the original SOFA. External valida-
tion of our model should be undertaken to conﬁ  rm its clinical utility.     
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  Prognosis for ICU Patients With Cirrhosis 
proportion of patients. Sepsis in the presence of cirrhosis 
is associated with poor prognosis; mortality rates increase 
with increasing number of failing organs     (  1,2  ). Despite some 
recent evidence suggesting improving outcomes in acutely ill 
patients with cirrhosis, in part due to the better understand-
ing of disease processes and improving ICU care (  3,4  ), the 
overall prognosis for patients with cirrhosis admitted to ICU 
remains poor with mortality rates ranging from 44 to 81  %   (  5  ). 
Considering the high cost of adjunctive treatment modalities 
(  6  ) and the limited availability of ICU beds, the task of iden-
tifying patients who are most likely to benefit from aggressive 
treatment is imperative, and poses great challenge for the clini-
cians involved in the care of these patients (  5,7  ). Unfortunately, 
the quest for an accurate prognostic score applicable to these 
patients in clinical practice has remained elusive (  5  ). 
 Th  e Child-Pugh score and the Model for End-Stage Liver 
Disease (MELD) are widely utilized for grading of the sever-
ity of liver disease and for liver graft   allocation for patients with 
decompensated cirrhosis. Th  ey are also used to assess prognosis 
for patients with cirrhosis admitted to ICU. However, general 
ICU prognostic scores, such as the Acute Physiology and Chronic 
Health Evaluation (APACHE) and the Sequential Organ Failure 
Assessment (SOFA) scores, have proven more accurate than the 
currently used liver-specifi  c models in predicting mortality, despite 
the fact that they are not derived specifi  cally from populations of 
patients  with  cirrhosis  ( 3,8 – 16 ).  Th  is  fi  nding reinforces the contri-
bution of multi-organ dysfunction in determining outcome, irre-
spective of the nature of underlying disease, and holds true even 
for patients with cirrhosis. 
 Th   ere are only three prognostic models (  3,9,15  ) that have been 
developed from cohorts ( n     =    111, 196, and 312) of ICU patients with 
cirrhosis. Some incorporate parameters such as serum sodium and 
lactate levels, which are highly predictive of outcome in the context 
of acute deterioration of chronic liver disease. Although most of 
these models demonstrate good discriminative ability, their cali-
bration, i.e., the concordance between predicted and observed out-
come, is modest at best. Th   erefore, to date none of the proposed 
models have been widely used. 
  Recently, a modifi  cation of SOFA, the Chronic Liver Failure-
SOFA (CLIF-SOFA) score, has been proposed for patients with 
cirrhosis hospitalized for acute decompensation (  17  ). According 
to this score, acute-on-chronic-liver-failure (ACLF) was defi  ned, 
including three ACLF grades (ACLF 1  –  3). ACLF 1 includes (a) 
patients with single renal failure (creatinine  ≥ 177    μ mol / l),  (b) 
patients with single-organ failure and creatinine from 133 to 
168    μ mol / l  and / or  mild-to-moderate  hepatic  encephalopathy, 
or (c) patients with single-cerebral failure (hepatic encephalopa-
thy grade 3 or 4) and creatinine from 133 to 168        μ mol / l.  ACLF 
2 includes patients with two failing organs, and ACLF 3 patients 
with three or more failing organs. Th   e 28-day mortality was 4.7  %   
in those without ACLF, 22.1  %   in grade 1 ACLF, 32  %   in grade 2 
ACLF, and 76.7  %   in grade 3 ACLF. Th  e performance of CLIF-
SOFA has not as yet been validated in cohorts other than the initial 
one from which it was derived. 
 Th  e aims of our study were the following: (a) to identify 
predictors of mortality in a cohort of patients with cirrhosis 
admitted to ICU, (b) to generate a novel calibrated prognos-
tic score for these patients (Royal Free Hospital (RFH) score), 
and (c) to compare the performance of the novel model to that 
of established liver-specifi  c (Child-Pugh, MELD, and MELD-
sodium), and general ICU prognostic models (APACHE II and 
SOFA) as well as the CLIF-SOFA score in more recent cohort 
(2005 – 2012).   
  METHODS 
 Th  e study population included consecutive patients with 
cirrhosis admitted to ICU between 1989 and 2012 at the 
RFH, a tertiary referral center in the United Kingdom for liver 
diseases and liver transplantation. Th  e diagnosis of cirrhosis 
was established by presence of portal hypertension (ascites, 
gastro-esophageal varices, hepatic encephalopathy, and so on), 
liver imaging studies, and liver biopsy if performed. Patients 
with acute liver failure, post-liver transplantation or other post-
operative hepatobiliary admissions to ICU were excluded. All 
patients received optimal treatment according to local guide-
lines, including regular screening for infections according to 
local ICU protocols. 
  Admissions to ICU were divided into quartiles corresponding 
to four study periods: 1989 – 1996 ( n     =    156), 1997 – 2004 ( n     =    158), 
2005 – 2008  ( n     =    160),  and  2009 – 2012  ( n     =    161).  Data  on  age, 
gender, etiology of liver disease, indication for ICU admission, 
length of ICU stay, and in-hospital mortality were available 
for all patients. Laboratory parameters recorded on the day of 
admission to the ICU included white blood cell count, platelet 
count, international normalized ratio (INR), urea, creatinine, 
sodium, potassium, albumin, bilirubin, lactate, pH, partial arte-
rial pressure of oxygen (PaO  2  ) and carbon dioxide (PaCO  2 ), 
inspired oxygen concentration (FiO2), oxygenation index (FiO  2  /
 PaO 2  ), and alveolar arterial partial pressure oxygen gradient 
(A-a gradient). 
 Th  e severity of liver disease was graded by the Child-Pugh, 
MELD, and MELD-sodium scores, using parameters on the day 
of admission to the ICU. Th   e acute physiology scores used were 
APACHE II and SOFA, as these two are consistently reported as 
the best prognostic scores for patients with cirrhosis admitted to 
ICU (  5,18  ). 
  For the subset of patients admitted between 2005 and 2012, the 
CLIF-SOFA score was also calculated and patients were classifi  ed 
as ACLF 0  –  3. Th  e number of failing organ systems (FOSs) was 
assessed using both the SOFA (SOFA  ≥  3 for failing organs) and the 
CLIF-SOFA criteria as described previously (  17  ) (FOS-SOFA and 
FOS-CLIF, respectively). 
 In-hospital mortality, rather than ICU mortality, was assessed, 
in order to include patients who died aft  er discharge to the 
ward, i.e., patients for whom further aggressive treatment was 
withdrawn because of futility, and because of low chances of 
recovery.  The American Journal of GASTROENTEROLOGY  VOLUME 109 | APRIL 2014   www.amjgastro.com
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  Statistical analysis 
  Data were expressed as mean and s.d. for continuous and nor-
mally distributed variables, median and range for continuous 
variables without normal distribution, or frequencies (percent-
age) for categorical variables. We compared survivors with 
non-survivors with regard to demographic and laboratory vari-
ables, as well as liver-specifi  c and acute physiology scores. For 
comparisons, the     χ    2  -test was used for categorical variables; the 
Student ’ s   t  -test and the Mann  –  Whitney test was used for con-
tinuous variables with or without normal distribution, respec-
tively. For comparisons between more than two groups, the 
Kruskal  –  Wallis test was applied. Univariate analysis was used 
to identify parameters associated with in-hospital mortality. 
Multiple logistic regression (backward: likelihood ratio (LR) 
method) was used for multivariate analysis, and the coeffi   cients 
derived were used to generate a prognostic model (RFH score). 
Th  e RFH score was developed and validated using a training 
set (75  %   of the population) and a validation set (25  %  ). Th  e  two 
sets were selected using a random number generator and 
checked for distribution of the year of admission. Th  e per-
formance of established prognostic scores, as well as the RFH 
score, was evaluated: the area under the receiver operating 
characteristic (AUROC) curve assessed the discriminative 
ability, whereas the Hosmer  –  Lemeshow goodness-of-fi  t      χ    2 -
test assessed the calibration of each model, with lower     χ    2   and 
higher   P   values indicating better calibration. Th   e Youden index 
was used to identify the optimal cutoff   point for each model, 
and the corresponding sensitivity, specifi   city, PPV (positive 
predictive value), NPV (negative predictive value), LR posi-
tive  (LR    +    )  and  negative  (LR    −    )  were  calculated.  Th  e level of 
statistical signifi   cance was set at   P  ≤  0.05. Statistical analysis 
was performed using the Statistical Package for Social Sciences, 
version 20 (SPSS, Chicago, IL).       
  RESULTS   
  Baseline characteristics, scoring, and outcomes 
  A total of 635 consecutive     patients with cirrhosis were admitted 
to the RFH ICU between 1989 and 2012 (  Supplementary Table 
S1   online).  Th   ere were 395 men (62.4  %  ) and, the mean age was 
50.5  ±  11.7 years (range 17  –  88 years). Alcoholic liver disease was 
the most common etiology of cirrhosis (63.3  %  ), followed by 
chronic viral hepatitis B and C (16.2  %  ). Th   e majority of patients 
had advanced liver disease, as refl  ected by the median MELD 
score of 22 and Child-Pugh class distribution (B 18.4  %   and C 
80.6 % ).  Th  e main indications for ICU admission were variceal 
bleeding (39.1 % ) and sepsis (23.9 % ). Th   e mean length of ICU stay 
was  7.7 ± 8  days.  Th   ree hundred and thirty-two patients (52.3  %  ) 
died either in the ICU or aft  er being discharged to the ward. ICU 
mortality  was  30.2 % .   
  Temporal change in outcomes and disease severity threshold for 
ICU admission between 1989 and 2012 
 In-hospital  mortality  signifi   cantly improved over time, from 
71.8 %   in  1989 – 1996  to  60.8 %   in  1997 – 2004,  41.9 %   in  2005 – 2008, 
and 35.4 %  in 2009 – 2012   ( P     <    0.0005;  Table 1 ). However, the sever-
ity of illness threshold for admitting patients to the ICU decreased 
over time, as refl  ected by both less severe liver-specifi  c scores and 
acute physiology scores at the time of admission to ICU in subse-
quent cohorts in the four quartiles between 1989 and 2012. ICU 
mortality did not change signifi  cantly over time.     
  Predictors of in-hospital mortality 
  Non-survivors were slightly older than survivors (median age 
52 vs. 50) and were more commonly admitted with sepsis (30.7 
vs. 16.6  %  ), renal failure (14.8 vs. 4  %  ), or multi-organ failure (9.9 
vs. 1.7  %  ), whereas survivors presented more oft  en with variceal 
bleeding (55 vs. 24.7  %  ). Th  ere was no signifi  cant diff  erence in 
    Table 1  .       Time trends of in-hospital mortality and disease severity on admission to intensive care unit     
           1989  –  1996       1997  –  2004       2005  –  2008       2009  –  2012         P     
      In-hospital mortality (  %  )   112 (71.8)    96 (60.8)    67 (41.9)    57 (35.4)          <      0.0005    a     
        Child-Pugh class (  %  )   
           A   1 (0.7)    3 (2.1)    0 (0)    1 (1.1)    0.448    a     
           B   28 (19.4)    29 (20)    23 (20)    11 (12.2)     
           C   115 (79.9)    113 (77.9)    92 (80)    78 (86.7)     
      Child-Pugh score    11.5 (6  –  15)   11 (5  –  15)   11 (7  –  15)   12 (6  –  15)   0.203    b     
      MELD   25.8 (9  –  40)   24.2 (6  –  40)   22.5 (8  –  40)   17.9 (7  –  40)         <      0.0005    b     
      MELD-sodium   28 (11  –  82)   23.6 (1  –  40)   21.7 (5  –  40)   17.8 (3  –  74)         <      0.0005    b     
      SOFA   12 (2  –  21)   10 (0  –  19)   8 (1  –  31)   8 (0  –  17)         <      0.0005    b     
      APACHE II    18 (2  –  41)   19 (0  –  44)   15 (6  –  42)   14 (5  –  25)         <      0.0005    b     
          APACHE, Acute Physiology and Chronic Health Evaluation; MELD, Model for End-Stage Liver Disease; SOFA, Sequential Organ Failure Assessment.     
      a            χ      2  -test.     
      b        The Kruskal  –  Wallis test.     © 2014 by the American College of Gastroenterology  The American Journal of GASTROENTEROLOGY
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  However, in multivariate analysis, only indication for ICU admis-
sion, bilirubin, INR, lactate, urea, and A-a gradient were independent 
predictors of in-hospital mortality. Th   e following score was generated 
using  the  75 %   training  sample:  RFH    score    =        −    2.692    −    0.996 * (variceal 
bleeding)    +    0.003 * (bilirubin)    +    0.358 * (INR)    +    0.136 * (lactate)    +    0.004 * 
(A-a  gradient)    +    0.036 * (urea).   
  Performance of prognostic models 
 Th  e AUROC for the RFH score was 0.826. in the training set 
and 0.797 in the validation set. Th  e  goodness-of-fi  t     χ    2   was  3.747 
gender distribution and the length of ICU stay between survivors 
and non-survivors (all   P     <    0.05;   Table 2 ). 
 Survivors had signifi  cantly lower median Child-Pugh (11 vs. 12), 
MELD (18 vs. 26), and MELD-sodium score (19 vs. 28). Th  e  SOFA 
(8 vs. 12) and the APACHE II scores (14 vs. 19) were signifi  cantly 
higher among non-survivors (all   P     <    0.05;   Table 3 ). 
  On the day of admission to the ICU, non-survivors had signifi  -
cantly lower serum sodium, arterial pH, PaO  2   and  PaO 2  / FiO2,  and 
higher white blood cell count, serum urea, creatinine and bilirubin, 
higher INR, arterial lactate, FiO  2  , and A-a gradient (all   P     <    0.05; 
  Table 3 ). 
  Parameters associated with in-hospital mortality in the univari-
ate analysis were indication for ICU admission, serum sodium, 
urea, creatinine and bilirubin, INR, platelet, and white blood 
cell counts, arterial lactate, pH, PaCO  2 ,  FiO 2 ,  PaO 2  / FiO 2 ,  and  A-a 
gradient (  Table 4 ). 
    Table 2  .       Baseline characteristics of in-hospital survivors and 
non-survivors     
       
    Non-survivors 
(  N  =332)   
    Survivors 
(  N  =303)         P     
      Age (years)    52 (18  –  80)   50 (17  –  88)   0.046 
        Gender (  %  )   
           Male   198 (59.8)    197 (65.2)    0.186 
           Female   133 (40.2)    105 (34.8)     
        Liver disease (  %  )            
           Alcoholic liver disease    207 (62.5)    195 (64.4)     
             Autoimmune hepatitis, pri-
mary sclerosing cholangitis, 
primary biliary cirrhosis, 
Wilson’s disease 
  27 (8.2)    19 (6.3)     
           Chronic hepatitis C    39 (11.8)    19 (6.3)    0.04 
           Chronic hepatitis B    25 (7.6)    20 (6.6)     
           Cryptogenic cirrhosis    9 (2.7)    12 (4)     
             Alcoholic liver disease and 
viral hepatitis 
  10 (2.5)    10 (3.3)     
           Other   14 (4.2)    28 (9.2)     
        Indication for ICU admission 
(  %  )   
         
           Respiratory failure    14 (4.2)    9 (3)     
           Sepsis   102 (30.7)    50 (16.6)     
           Renal failure    49 (14.8)    12 (4)          <      0.0005 
           Multiorgan failure    33 (9.9)    5 (1.7)     
           Variceal bleeding    82 (24.7)    170 (56.3)     
           Encephalopathy   25 (7.5)    20 (6.6)     
           Other   27 (8.1)    36 (11.9)     
      Length of ICU stay (days)    a       5 (0  –  42)   5 (0  –  71)   0.408 
          ICU, intensive care unit.     
      a        Median (range).     
      Table 3  .       Characteristics of in-hospital survivors and non-survivors 
on the day of admission to intensive care unit     
       
    Survivors 
(  N  =303)   
    Non-survivors 
(  N  =332)         P     
      Sodium (mmol  /  l)   140 (104  –  178)   137 (107  –  172)   0.003 
      Potasium (mmol  /  l)   4.1 (2.3  –  8.7)   4.2 (1.7  –  7.2)   0.419 
      Creatinine (  μ  mol  /  l)   78 (35  –  2759)   126 (21  –  1252)         <      0.0005 
      Urea (  μ  mol  /  l)   8.1 (0.2  –  72)   11.9 (0.6  –  52.5)         <      0.0005 
      Bilirubin (  μ  mol  /  l)   52 (5  –  667)   125 (2  –  1058)         <      0.0005 
      Albumin (g  /  l)   26 (8  –  58)   27 (6  –  53)   0.298 
      White blood cells 
(  ×  10  9    /  l) 
  8.54 
(0.84  –  64.37) 
  11.2 (1.3  –  52)         <      0.0005 
      Platelets (  ×  10  9    /  l)   77 (11  –  824)   73 (8  –  371)   0.053 
      INR   1.8 (0.8  –  8)   2.3 (1.09  –  10.2)         <      0.0005 
      Lactate (mmol  /  l)   1.7 (0.14  –  18.3)   3.28 
(0.19  –  22.7) 
        <      0.0005 
      pH   7.4 (7.1  –  7.59)   7.36 
(6.46  –  7.64) 
        <      0.0005 
      PaO  2   (kPA)    14.2 
(3.49  –  59.76) 
  13.19 
(2.4  –  63.5) 
  0.029 
      PaCO  2   (kPA)    4.7 (2.74  –  8.8)   4.8 (1.14  –  20.5)   0.202 
      FiO  2     0.5 (0.1  –  1)   0.6 (0.1  –  1)         <      0.0005 
      PaO  2    /  FiO  2     227 (44  –  910)   187 (18  –  790)         <      0.0005 
      A-a gradient    186 
(      −      336 to 617) 
  243 
(      −      58 to 619) 
        <      0.0005 
      SOFA   8 (0  –  31)   12 (2  –  21)         <      0.0005 
      MELD   18 (6  –  40)   26 (9  –  40)         <      0.0005 
      MELD-sodium   18.9 (1  –  74)   28 (4  –  82)         <      0.0005 
      Child-Pugh score    11 (5  –  15)   12 (7  –  15)         <      0.0005 
      Child-Pugh class (  %  )               <      0.0005 
           A   5 (2.2)    (0)    
           B   67 (29.6)    24 (9)     
           C   154 (68.1)    244 (91)     
      APACHE II    14 (0  –  31)   19 (6  –  44)         <      0.0005 
          A-a gradient, alveolar-arterial partial pressure oxygen gradient; APACHE, Acute 
Physiology and Chronic Health Evaluation; INR, international normalized ratio; 
MELD, Model for End-stage Liver Disease; SOFA, Sequential Organ Failure 
Assessment.     
          All values expressed as median (range).     The American Journal of GASTROENTEROLOGY  VOLUME 109 | APRIL 2014   www.amjgastro.com
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admitted to ICU between 2005 and 2012, 74 (24.2  %  ) had no 
ACLF, 89 (29.1  %  ) had ACLF 1, 80 (26.1 % ) ACLF 2, and 63 (20.6 % ) 
ACLF 3. Mortality in those without ACLF was 18.9  %  , ACLF 1 
23.6 % , ACLF 2 53.8 % , and ACLF 3 66.7 %  ( Figure 3 ). Th  e  AUROC 
for the diff  erent scores was the following: Child-Pugh 0.68, MELD 
0.73, MELD-sodium 0.71, APACHE II 0.73, SOFA 0.74, FOS-
SOFA 0.66, CLIF-SOFA 0.75, FOS-CLIF 0.73, and RFH 0.78. Th  e 
goodness-of-fi  t     χ    2   was the following: Child-Pugh 4.89 (  P     =    0.43), 
MELD 2.81 ( P     =    0.95), MELD-sodium 6.91 ( P     =    0.55), APACHE II 
11.26 (  P     =    0.13),  SOFA  6.21  ( P     =    0.63),  FOS-SOFA  3.33  ( P     =    0.19), 
CLIF-SOFA 9.18 (  P     =    0.33),  FOS-CLIF  3.72  ( P     =    0.29),  and  RFH 
2.91 (  P     =    0.94;   Supplementary Table S2 ).    
  DISCUSSION 
  Prognosis for patients with cirrhosis admitted to the ICU is poor 
(  7  ) and even worse than that in critically ill patients without cir-
rhosis (  2  ). We developed a novel prognostic model, the RFH 
score, for critically ill patients with cirrhosis. Parameters included 
in this score refl  ect both hepatic and extrahepatic organ failure 
contributing to high mortality rates. Th  e RFH score performed 
better than established     and commonly used acute physiology and 
liver-specifi  c scores in our cohort, and better than the recently 
proposed CLIF-SOFA score. 
  Several studies evaluated optimal prognostic scores for patients 
with cirrhosis admitted to ICU. Despite the unequivocal need 
(  P     =    0.879)  in  the  training  set  and  9.029  ( P     =    0.340)  in  the  valida-
tion set. Th  e  classifi  cation accuracy of the score was 73.4  %   in the 
training sample and 76.7 %  in the validation sample. Th  e  classifi  ca-
tion accuracy of the RFH score was assessed in the four diff  erent 
time  periods:  82.6 %   in  1989 – 1996,  79.7 %   in  1997 – 2004,  75.8 %   in 
2005 – 2008,  and  75.2 %   in  2009 – 2012. 
 Th   e AUROC and goodness-of-fi  t     χ    2   for the established prognos-
tic models in the validation sample were, respectively, the follow-
ing: SOFA: 0.785 and 9.255 (  P     =    0.321),  MELD:  0.749  and  7.672 
(  P     =    0.466),  APACHE  II:  0.736  and  11.133  ( P     =    0.219),  MELD-
sodium: 0.716 and 10.598 (  P     =    0.226),  and  Child-Pugh:  0.707 
and 3.260 (  P     =    0.660).  Th  e  AUROC  and  goodness-of-fi  t     χ    2   for the 
diff  erent models in the training and validation set are displayed 
in  Table 5 . Th   e ROC curves for the diff  erent prognostic models are 
in both the training and validation sample displayed in   Figure 1 . 
 Th   e optimal cutoff   point according to best Youden index for each 
score, and corresponding sensitivity, specifi   city,  PPV,  NPV,  LR    +    , 
and  LR    −      are  shown  in   Table 6  . For the RFH score, the optimal cut-
off     of      −    0.82  conferred  a  sensitivity  of  85.7 % ,  specifi  city of 59.3  %  , 
PPV  0.71,  NPV  0.78,  LR    +      2.1,  and  LR    −      0.24.  Th   e correctly classi-
fi  ed cases using this cutoff   point are shown graphically in   Figure 2 .   
  Prognostic models in patients admitted between 2005 and 2012 
  A subgroup analysis was performed for the 2005  –  2012 
cohort, as this was the time period with the lowest in-hospital 
mortality compared with earlier time periods. Of the 306 patients 
    Table 4  .       Predictors of in-hospital mortality (training sample)     
      Univariate analysis      Multivariate analysis  —  parameters included in the 
Royal Free Hospital score   
           OR       95  %   CI             P         OR       95  %   CI         P     
        Indication   
           Sepsis   1.199   0.780  –  1.843   0.407          
           Variceal bleeding    0.290   0.200  –  0.422         <      0.0005   0.369   0.222  –  0.615         <      0.0005 
           Other                   
      Sodium   0.977   0.961  –  0.994   0.008          
      Creatinine   1.003   0.1.001  –  1.004         <      0.0005          
      Urea   1.048   1.028  –  1.096         <      0.0005   1.036   1.010  –  1.064   0.007 
      Bilirubin   1.005   1.004  –  1.007         <      0.0005   1.003   1.001  –  1.005   0.002 
      White blood cells    1.043   1.020  –  1.067         <      0.0005          
      Platelets   0.997   0.995  –  0.999   0.007          
      INR   2.135   1.73  –  2.634         <      0.0005   1.431   1.063  –  1.926   0.018 
      Lactate   1.250   1.168  –  1.339         <      0.0005   1.145   1.040  –  1.260   0.006 
      PH   0.016   0.04  –  0.64         <      0.0005          
      PaCO  2     1.172   1.034  –  1.328   0.013          
      FiO  2     11.939   5.045  –  28.256         <      0.0005          
      PaO  2    /  FiO  2     0.997   0.996  –  0.999         <      0.0005          
      A-a gradient    1.004   1.002  –  1.005         <      0.0005   1.004   1.002  –  1.006         <      0.0005 
          A-a gradient, alveolar-arterial partial pressure oxygen gradient; CI, conﬁ  dence interval; INR, international normalized ratio; OR, odds ratio.     © 2014 by the American College of Gastroenterology  The American Journal of GASTROENTEROLOGY
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 Th   e performance of already established scores  —  both liver-spe-
cifi  c and acute physiology scores  —  has been assessed extensively 
( 3,8,10 – 14,16,20 – 28 ).  Published  studies  consistently  showed 
that general ICU scores perform better than liver-specifi  c scores. 
SOFA yielded the best predictive accuracy, whereas Child    -Pugh 
had the worst accuracy. SOFA was usually more accurate than 
MELD score. In our study, SOFA had the best predictive accuracy, 
followed by MELD, APACHE II, and MELD-sodium. Child-Pugh 
was the least accurate, probably because it does not incorporate 
parameters of renal function. With regard to calibration, MELD 
showed the best goodness-of-fi  t   P   value. When we compared the 
updated RFH score with the above-established models, we found 
that it had better predictive accuracy, even better than SOFA and 
much better than MELD. When we validated our model in the 
25 %  validation sample, the predictive accuracy was inferior (over-
fi  tting in the training sample from which it derived), but still bet-
ter than the rest of the scores. MELD and Child-Pugh showed the 
best calibration in the validation sample. 
 Th   e CLIF-SOFA, a modifi  cation of SOFA for patients with cirrhosis, 
and the ACLF classifi  cation have been recently proposed for patients 
with cirrhosis presenting with acute decompensation. A signifi  cant 
proportion of patients was already in ICU or they were admitted 
shortly thereaft  er (a total of 23.9 % ). In the subset of patients admitted 
to ICU between 2005 and 2012, 75  %   met the criteria of ACLF but 
25  %   did not. Mortality was signifi  cantly higher in those with ACLF 
grade 2 and 3. Nevertheless, the RFH score performed slightly better 
than the CLIF-SOFA and SOFA, which had similar performance. 
 Th   e severity of the underlying liver disease is a major contribu-
tor to the outcome. Th   e majority of our patients had advanced liver 
disease on admission with median MELD score of 22. Non-survi-
vors had more severe liver disease, 91  %   being classifi  ed as Child-
Pugh C, with median MELD score of 26, while 68  %   of survivors 
were Child-Pugh class C, with median MELD score of 18. Indi-
ces of liver dysfunction, such as bilirubin and INR, were included 
in the RFH score. Albumin was not a signifi  cant predictor of mor-
tality in our study. Intravenous albumin may have been admin-
istered before ICU admission for indications such as hepatorenal 
syndrome or large volume paracentesis, which may have accounted 
for the lack of association with mortality. 
for disease-specifi   c scores, only a few studies have generated 
novel prognostic models from critically ill patients with cirrhosis 
(  3,9,15  ), and even so these have not been widely endorsed. Zauner 
  et al.   (  15  ) generated the   “  intensive care cirrhosis outcome score  ”   
(ICCO) from 196 patients with cirrhosis, which included bilirubin, 
cholesterol,  creatinine  clearance,  and  lactate  (AUROC    =    0.9,  but 
calibration not reported in the article) (  15  ). Th   e   “ mean  arterial 
pressure, bilirubin, respiratory failure, and sepsis  ”   (MBRS) score 
was   derived from a study population ( n     =    111) with very high mor-
tality rate (81  %  ) including mainly patients with hepatitis B and 
hepatocellular  carcinoma  (AUROC    =    0.9  for  in-hospital  mortality, 
  P     =    0.268  for  the  goodness-of-fi  t     χ    2 )  ( 9 ).  Th  e original RFH score 
was developed from a cohort of patients (  n     =    312)  with  cirrhosis 
admitted to the RFH ICU between 1989 and 2005, and included 
the number of failing organs, bilirubin, urea, FiO  2  , and lactate 
(AUROC    =    0.83,   P     =    0.48  for  the  goodness-of-fi  t     χ    2 )  ( 3 ).  Th  e  origi-
nal RFH score was subsequently validated in a cohort of patients 
with cirrhosis admitted to a general ICU and was found to perform 
better than both acute physiology and liver-specifi  c scores, indicat-
ing the potential utility of this score in clinical practice (  19  ). 
  In the current updated RFH score, parameters included are 
bilirubin, INR, lactate, urea, A-a gradient, and variceal bleeding as 
the indication for ICU admission. Patients with variceal bleeding 
are oft  en intubated only to protect the airway, and therefore have 
more favorable prognosis than patients with other indications for 
ICU admission. In addition, terlipressin and transjugular intrahe-
patic portosystemic shunts have signifi  cantly improved survival 
in these patients. Urea is an important surrogate of renal function 
and was included in the updated RFH model. Platelets did not 
improve the performance of the model and thus were not included. 
A-a gradient is a better marker of respiratory function than FiO  2 ; 
thus, its inclusion in the fi  nal model improved performance. We 
did not include the number of failing organs in the updated RFH 
score, as we chose to use only simple, directly measurable param-
eters. Despite simplifying the model, the discriminative ability and 
calibration remained good. Th  e  classifi  cation accuracy of the RFH 
score remained good in the diff  erent eras of admission, although 
somewhat less good in more recent years, likely due to lower 
number of events-deaths in the later time frame. 
    Table 5  .       Predictive ability for mortality of different prognostic models for patients with cirrhosis admitted to intensive care unit (training 
and validation set)     
           Training set       Validation set   
        Prognostic model       AUROC       Goodness-of-ﬁ  t     χ          2      (  P   value)       AUROC       Goodness-of-ﬁ  t     χ          2      (  P   value)   
      RFH score    0.826   3.747 (0.879)    0.797   9.029 (0.340) 
      SOFA   0.810   7.343 (0.500)    0.785   9.255 (0.321) 
      MELD   0.787   6.600 (0.580)    0.749   7.672 (0.466) 
      APACHE II    0.780   9.375 (0.312)    0.736   11.133 (0.219) 
      MELD-sodium   0.762   6.259 (0.618)    0.716   10.598 (0.226) 
      Child-Pugh   0.668   3.587 (0.610)    0.707   3.260 (0.660) 
          APACHE, Acute Physiology and Chronic Health Evaluation; AUROC, area under the receiver operating characteristic curve; MELD, Model for End-stage Liver Disease; 
RFH, Royal Free Hospital; SOFA, Sequential Organ Failure Assessment.     The American Journal of GASTROENTEROLOGY  VOLUME 109 | APRIL 2014   www.amjgastro.com
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worse in non-survivors on admission to the ICU, with A-a gradi-
ents and urea being incorporated in our prognostic model. Urea 
is also a surrogate of intravascular volume depletion, which may 
account for its inclusion in the model rather than creatinine, which 
can be   “  falsely low  ”   in malnourished patients. 
  Lactate is a component of prognostic scores for acute liver fail-
ure, but it is also an important indicator of systemic derangement 
related to sepsis and circulatory failure. In patients with acute dete-
rioration of chronic liver disease, high lactate levels might be due 
to the precipitating event, such as sepsis, respiratory, or cardiac 
failure. Following resuscitation, persistent high lactate levels might 
refl  ect the severity of the underlying liver disease. Th   us, the dual 
role of lactate as a surrogate marker of both hepatic and extrahe-
patic organ failure may account for its high prognostic value (  31  ). 
  Although outcomes have improved over time (  3  ) mortality rates 
for critically ill patients with cirrhosis remain high (  8,9,14,16,
20  –  23,29,32,33  ). In our unit, in-hospital mortality decreased from 
72 %   in  1989 – 1996  to  42 %   in  2005 – 2008  and  35 %   in  2009 – 2012. 
Th   e improvement in survival may be and the advent of novel thera-
peutic modalities, such as terlipressin and transjugular intrahepatic 
portosystemic shunts, which are highly eff  ective in treating com-
plications of portal hypertension, in particular variceal bleeding 
( 34 ).  Galbois   et al.   (  4  ) showed that mortality improved in 2005  – 
2008 compared with 1995  –  1998, although patients admitted to 
ICU between 2005 and 2008 had signifi  cantly higher Child-Pugh, 
MELD, and SOFA scores (  4  ). Th   is was not the case in our study, as 
we showed that the threshold for admitting patients with cirrho-
sis to ICU has signifi  cantly decreased in our unit; thus, aggressive 
treatment was initiated at an earlier stage, which may also account 
for improving overall in-hospital survival in our cohort. Neverthe-
less, the cost of current therapeutic modalities is high (  6  ), which 
further underlies the need for risk stratifi  cation and identifi  cation 
of patients who would mostly benefi  t from them. 
  We developed a prognostic score, the RFH score, for patients 
with cirrhosis admitted to ICU that incorporates few easily meas-
urable parameters, and combines very good discriminative ability, 
comparable to SOFA, with good calibration. Our study included 
a large number of patients admitted to ICU over a long period of 
time during which medical practice and indications for ICU admis-
sion have changed. Th   e validation of our model using training and 
validation cohorts, as well as in the diff  erent time frames, supports 
its generalizability. However, external validation in other cohorts 
of patients with cirrhosis in the ICU is needed. Such a model could 
serve as an important adjunct to clinical judgment in order to iden-
tify patients with cirrhosis who are highly unlikely to benefi  t from 
initiating aggressive treatment or continuing treatment in an ICU, 
especially in the context of prioritization for ICU bed allocation 
and the high cost of current treatment. In the   “  real world  ”  , patients 
with cirrhosis admitted to ICU for indications other than variceal 
bleeding, with high bilirubin, INR, lactate, urea, and A-a gradient, 
on admission to ICU have very low chances of survival. Finally, the 
CLIF-SOFA and the ACLF classifi  cation, although derived from a 
large cohort of patients with acute deterioration, do not seem to 
perform better than the original SOFA and the commonly used 
MELD score in patients with cirrhosis admitted to ICU.         
  Extrahepatic organ failure is another major predictor of mortal-
ity. Th   e number of FOS has been strongly associated with mortal-
ity in ICU patients with cirrhosis (  3,13,21,23  ). Mortality exceeds 
90  %   with more than three FOS (  3,21  ). In our 2005  –  2012 cohort, 
mortality among patients with more than three FOS, according to 
both SOFA and CLIF-SOFA criteria, was 67  %  . Among diff  erent 
organs, renal failure has the most profound impact on survival 
(  11,20,29,30  ). Indices of renal (urea and creatinine) and respira-
tory function (FiO  2 , PaO 2  / FiO 2 , and A-a gradient) were signifi  cantly 
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    Figure 1  .                 Receiver operating characteristic curve for the different prognos-
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  Study  Highlights  
    WHAT IS CURRENT KNOWLEDGE   
   3  Patients with cirrhosis admitted to intensive care unit (ICU) 
have high mortality. 
   3  Various prognostic models have been developed and applied, 
but only three models were derived from patients with cir-
rhosis  —  all other studies have used ICU scores, among which 
Sequential Organ Failure Assessment (SOFA) is the best. 
   3  Only three models exist with calibration, i.e., observed  /
  expected deaths, whereas most only report a comparison 
of discrimination of the models (area under the receiver 
operating characteristic (AUROC) curves). 
    WHAT IS NEW HERE   
   3  We have derived a model based on patients with cirrhosis 
consecutively admitted to ICU. 
   3  We have a calibrated model with good statistical validity. 
   3  We have included comparison with the new proposed Chronic 
Liver Failure (CLIF)-SOFA, which has been modeled on 
patients with cirrhosis, acute decompensation, and multi-
organ failure, and strictly evaluated time eras of admission. 
   3  The derived model has better statistical accuracy than pre-
vious models and the CLIF-SOFA score. It uses bilirubin, 
international normalized ratio (INR), lactate, alveolar 
arterial partial pressure oxygen (A-a) gradient, urea, and 
variceal bleeding as indication for ICU admission. 
   3  The model uses easily recorded parameters and will help in 
assessing prognosis more accurately with a view to either 
continuing ICU care or earlier withdrawal of care. 
   3  The model has internal validation but will need external 
validation to conﬁ  rm generalizability.                              
    Table 6  .       Performance of different prognostic models in predicting mortality using the optimal cut-off point (validation set)     
        Prognostic model       Cutoff point       Youden index       Sensitivity (  %  )       Speciﬁ  city (  %  )       PPV       NPV       LR      +             LR      −         
      RFH score          −      0.82   0.45   85.7   59.3   0.71   0.78   2.1   0.24 
      SOFA   10.5   0.513   68   83.3   0.84   0.68   4.1   0.38 
      MELD   21   0.484   76.5   71.9   0.78   0.71   2.72   0.33 
      APACHE II    17.5   0.369   59.5   77.4   0.78   0.59   2.6   0.52 
      MELD-sodium   22.5   0.408   72.5   68.3   0.74   0.66   2.29   0.4 
      Child-Pugh   12.5   0.302   46.9   83.3   0.79   0.50   2.8   0.64 
          APACHE, Acute Physiology and Chronic Health Evaluation; LR      +      ; likelihood ratio positive; LR      −      , likelihood ratio negative; MELD, Model for End-Stage Liver Disease; NPV, 
negative predictive value; PPV, positive predictive value; RFH, Royal Free Hospital; SOFA, Sequential Organ Failure Assessment.     
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    Figure 2  .                 Performance of the Royal Free Hospital (RFH) score with the 
optimal cutoff point of       −      0.82 (validation sample).   
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